Reducing CLABSI rates at Barnes-Jewish Hospital became a priority in 2010 when a group of concerned ICU staff members rejected the belief that the patient population, typically adults that are immuno-compromised due to oncological complications, would naturally lead to a high rate of CLABSI. The hospital’s multi-disciplinary unit practice committee (UPC), which addresses issues impacting the delivery of patient care as well as staff and patient satisfaction, accepted the challenge of changing the ICU culture to ultimately reduce CLABSI rates.
In August 2010, the UPC appointed a team of staff nurse “champions” to complete a daily check-list for monitoring best practices in the maintenance of central line dressings. Nurse champions, as well as the advanced practicing nurse (APN) and nurse manager made daily rounds to ensure that dressings were properly changed. In addition, the committee reviewed and reinforced the hospital’s “Stop the Line” policy, requiring nurse presence throughout the line insertion process.
To ensure that all ICU staff was aware of best line insertion and maintenance practices, the hospital held a “Skills Day” to clarify optimal aseptic technique. The entire ICU team was reeducated on proper hand hygiene as well and monitored by monthly checks by a certified infection control liaison. To maintain the momentum, ICU staff developed individual dry erase boards monitoring each patient’s line information, including the dates of insertion, dressing and caps changes, to provide constant awareness of patient line maintenance.
Each month, the UPC presented the program’s results and achievements to the Clinical Practice Council, where issues impacting the practice environment are discussed and best practices are shared amongst the chairs.
90 Percent CLABSI Education: For 10 consecutive months from the start of the project, the 8900 ICU achieved a CLABSI rate of 0.28, well below the National Hospital Safety Network (NHSN) benchmark of 2.4 demonstrating an approximately 90 percent decrease in CLABSI.
- Significant improvement was evident from the 2008 and 2009 rate of 4.1, which was well above the NHSN benchmark of 2.4 and the January-July 2010 rate of 4.8, also significantly higher than the NHSN benchmark of 2.6.
ICU Team Culture Change: The 8900 ICU received full support from administrators, physicians and nursing staff.
- Nurse champions held themselves and others accountable for identifying and implementing compliance of central venous catheter maintenance.
- Nurses in the ICU were empowered to maintain their central lines from insertion to early removal, when applicable, to minimize the chance of infection. With the current ICU nursing practices in place, The 8900 ICU expects a CLABSI rate of zero for 2012.
- Maintained zero percent Clostridium difficile rate.
1. Blot SI, Depuydt P, Annemans L, et al. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis. 2005;41:1591–8.[PubMed]
2. Saint S, Veenstra DL, Lipsky BA. The clinical and economic consequences of nosocomial central venous catheter-related infection: are antimicrobial catheters useful? Infect Control Hosp Epidemiol. 2000;21:375–80.[PubMed]
3. Klevens RM, Edwards JR, Richards CL, Jr, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122:160–6.[PMC free article][PubMed]
4. McKee C, Berkowitz I, Cosgrove SE, et al. Reduction of catheter-associated bloodstream infections in pediatric patients: experimentation and reality. Pediatr Crit Care Med. 2008;9:40–6.[PubMed]
5. Marschall J, Mermel LA, Classen D, et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29(Suppl 1):S22–30.[PubMed]
6. Trick WE, Miranda J, Evans AT, Charles-Damte M, Reilly BM, Clarke P. Prospective cohort study of central venous catheters among internal medicine ward patients. Am J Infect Control. 2006;34:636–41.[PubMed]
7. Kallen AJ, Patel PR, O'Grady NP. Preventing catheter-related bloodstream infections outside the intensive care unit: expanding prevention to new settings. Clin Infect Dis. 2010;51:335–41.[PubMed]
8. Abedin S, Kapoor G. Peripherally inserted central venous catheters are a good option for prolonged venous access in children with cancer. Pediatr Blood Cancer. 2008;51:251–5.[PubMed]
9. Safdar N, Maki DG. Risk of catheter-related bloodstream infection with peripherally inserted central venous catheters used in hospitalized patients. Chest. 2005;128:489–95.[PubMed]
10. Sengupta A, Lehmann C, Diener-West M, Perl TM, Milstone AM. Catheter duration and risk of CLA-BSI in neonates with PICCs. Pediatrics. 2010;125:648–53.[PMC free article][PubMed]
11. Central Line-Associated Bloodstream Infection (CLABSI) Event. Available at: http://www.cdc.gov/nhsn/pdfs/pscmanual/4psc_clabscurrent.pdf. Accessed 3 December 2010.
12. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:1–45.[PMC free article][PubMed]
13. Linck DA, Donze A, Hamvas A. Neonatal peripherally inserted central catheter team. Evolution and outcomes of a bedside-nurse-designed program. Adv Neonatal Care. 2007;7:22–9.[PubMed]
14. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med. 2000;132:391–402.[PubMed]
15. de Jonge RC, Polderman KH, Gemke RJ. Central venous catheter use in the pediatric patient: mechanical and infectious complications. Pediatr Crit Care Med. 2005;6:329–39.[PubMed]
16. Feudtner C, Christakis DA, Connell FA. Pediatric deaths attributable to complex chronic conditions: a population-based study of Washington State, 1980–1997. Pediatrics. 2000;106:205–9.[PubMed]
17. Zaoutis T, Localio AR, Leckerman K, Saddlemire S, Bertoch D, Keren R. Prolonged intravenous therapy versus early transition to oral antimicrobial therapy for acute osteomyelitis in children. Pediatrics. 2009;123:636–42.[PMC free article][PubMed]
18. Chathas MK, Paton JB, Fisher DE. Percutaneous central venous catheterization. Three years' experience in a neonatal intensive care unit. Am J Dis Child. 1990;144:1246–50.[PubMed]
19. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr. 1974;19:716–23. 10.1109/TAC.1974.1100705.
20. Pronovost P. Interventions to decrease catheter-related bloodstream infections in the ICU: the Keystone Intensive Care Unit Project. Am J Infect Control. 2008;36(Suppl 171):e1–5.[PubMed]
21. Miller MR, Griswold M, Harris JM, 2nd, et al. Decreasing PICU catheter-associated bloodstream infections: NACHRI's quality transformation efforts. Pediatrics. 2010;125:206–13.[PubMed]
22. Wylie MC, Graham DA, Potter-Bynoe G, et al. Risk factors for central line-associated bloodstream infection in pediatric intensive care units. Infect Control Hosp Epidemiol. 2010;31:1049–56.[PubMed]
23. Mermel LA, McCormick RD, Springman SR, Maki DG. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med. 1991;91:197S–205S.[PubMed]
24. McLaws ML, Berry G. Nonuniform risk of bloodstream infection with increasing central venous catheter-days. Infect Control Hosp Epidemiol. 2005;26:715–9.[PubMed]
25. Odetola FO, Moler FW, Dechert RE, VanDerElzen K, Chenoweth C. Nosocomial catheter-related bloodstream infections in a pediatric intensive care unit: risk and rates associated with various intravascular technologies. Pediatr Crit Care Med. 2003;4:432–6.[PubMed]
26. Garcia-Teresa MA, Casado-Flores J, Delgado Dominguez MA, et al. Infectious complications of percutaneous central venous catheterization in pediatric patients: a Spanish multicenter study. Intensive Care Med. 2007;33:466–76.[PubMed]
27. Goes-Silva E, Abreu TF, Frota AC, Pessoa-Silva CL, Cunha AJ, Hofer CB. Use of peripherally inserted central catheters to prevent catheter-associated bloodstream infection in children. Infect Control Hosp Epidemiol. 2009;30:1024–6.[PubMed]
28. Milstone AM, Sengupta A. Do prolonged peripherally inserted central venous catheter dwell times increase the risk of bloodstream infection? Infect Control Hosp Epidemiol. 2010;31:1184–7.[PubMed]
29. Ullman RF, Gurevich I, Schoch PE, Cunha BA. Colonization and bacteremia related to duration of triple-lumen intravascular catheter placement. Am J Infect Control. 1990;18:201–7.[PubMed]
30. Schmidt-Sommerfeld E, Snyder G, Rossi TM, Lebenthal E. Catheter-related complications in 35 children and adolescents with gastrointestinal disease on home parenteral nutrition. JPEN J Parenter Enteral Nutr. 1990;14:148–51.[PubMed]
31. Christensen ML, Hancock ML, Gattuso J, et al. Parenteral nutrition associated with increased infection rate in children with cancer. Cancer. 1993;72:2732–8.[PubMed]
32. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. The Hospital Infection Control Practices Advisory Committee, Center for Disease Control and Prevention, U.S. Pediatrics. 2002;110:e51.[PubMed]
33. Goetz AM, Wagener MM, Miller JM, Muder RR. Risk of infection due to central venous catheters: effect of site of placement and catheter type. Infect Control Hosp Epidemiol. 1998;19:842–5.[PubMed]
34. Merrer J, De Jonghe B, Golliot F, et al. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA. 2001;286:700–7.[PubMed]
35. Hospitals: 2010 National patient safety goals. Available at: http://www.jointcommission.org/assets/1/18/NPSG_Chapter_Outline_FINAL_HAP_2010.pdf. Accessed 3 December 2010.